Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study

Lotte M. Knapen, Roy G. P. J. de Jong, Johanna H. M. Driessen, Yolande C. Keulemans, Nielka P. van Erp, Marie L. De Bruin, Hubert G. M. Leufkens, Sander Croes, Frank de Vries*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)401-411
Number of pages11
JournalDiabetes Obesity & Metabolism
Volume19
Issue number3
DOIs
Publication statusPublished - Mar 2017

Keywords

  • acute pancreatitis
  • chronic pancreatitis
  • cohort studies
  • dipeptidyl peptidase-4 inhibitors
  • glucagon-like peptide-1 receptor agonists
  • incretin-based therapy
  • type 2 diabetes mellitus
  • THERAPIES
  • CANCER
  • DRUGS
  • METAANALYSIS
  • ASSOCIATION
  • RATS
  • EXPANSION
  • BENEFITS
  • UPDATE
  • SYSTEM

Cite this